I've published
Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study.
Am. J. Hypertens., Jul;18(7):899-905 (2005)
BDNF-mediated enhancement of inflammation and injury in the aging heart.
Physiol. Genomics., Feb;24(3):191-7 (2006)
Left atrial systolic force and cardiovascular outcome. The Strong Heart Study.
Am. J. Hypertens., Dec;18(12 Pt 1):1570-6; discussion 1577 (2005)
Association of pulse pressure with cardiovascular outcome is independent of left ventricular hypertrophy and systolic dysfunction: the Strong Heart Study.
Am. J. Hypertens., Jun;19(6):601-7 (2006)
Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
J. Hypertens., Oct;24(10):2079-84 (2006)
Dr. Peter Okin
Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
J. Hypertens., May;25(5):1079-85 (2007)
Dr. Peter Okin
Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: the Strong Heart Study.
J Am Soc Echocardiogr., Jan;21(1):66-71 (2008)
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study).
Am. J. Cardiol., Jan;93(1):40-4 (2004)
Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study.
J Hum Hypertens., Jun;18(6):423-30 (2004)
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.
Am. J. Hypertens., Feb;18(2 Pt 1):191-6 (2005)
Dr. Jorge Kizer
Gender difference in diastolic function in hypertension (the HyperGEN study).
Am. J. Cardiol., May;89(9):1052-6 (2002)
Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study.
Am. J. Med., Jun;112(9):710-5 (2002)
Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
J. Hypertens., Jul;20(7):1445-50 (2002)
Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study.
J. Hypertens., Apr;21(4):781-7 (2003)
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.
J. Am. Coll. Cardiol., Jun;41(11):2022-8 (2003)
Influence of fat-free mass on detection of appropriateness of left ventricular mass: the HyperGEN Study.
J. Hypertens., Sep;21(9):1747-52 (2003)
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.
Diabetes Care., Oct;26(10):2764-9 (2003)
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study.
Circulation., Jan;103(1):102-7 (2001)
Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study .
Hypertension., May;37(5):1229-35 (2001)
Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study).
Am. J. Cardiol., Jun;87(11):1260-5 (2001)